Garden Biopharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 96.5114 million yuan, a year-on-year increase of 5.5%
I'm PortAI, I can summarize articles.
Garden Biopharmaceutical released its Q1 2025 earnings report, with operating revenue of 326 million yuan, a year-on-year decrease of 1.18%; net profit attributable to the parent company of 96.5114 million yuan, a year-on-year increase of 5.5%; net profit after deducting non-recurring gains and losses of 88.1384 million yuan, a year-on-year increase of 44.42%; basic earnings per share of 0.18 yuan/share
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments